About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
U
Can Diet and Nutrition Impact Multiple Myeloma Outcomes?
By
Oncology Data Advisor
FEATURING
Urvi Shah
,
Rahul Banerjee
April 27, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
14:41
Sanofi
Efficacy and Safety of a Treatment Option for Adults with Multiple M…
Feat.
J. Mikhael
Featured Video
15:52
Lilly
BTK Inhibition for Patients with MCL: Safety and Efficacy Data
Feat.
J. Pagel
Related Content
AUTOPLAY
ON
44:47
Scripps Health
Nutrition + Supplements in Cancer: Do's and Don'ts
Feat.
D. Abrams
18:26
William Schaffner
Shingles (Herpes Zoster) Vaccination in Adults: What is the Importan…
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
14:09
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…
Feat.
H. Hashmi
41:07
Yale Cancer Center
Understanding Your Cancer Risk and Options for Cancer Prevention
Feat.
V. Giri,
T. Shroff
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
03:17
Insights from 2023 IMS Annual Meeting
IMS 2023 Insights: "Highlights From the International Myeloma S…
Feat.
J. Richter
12:33
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myelom…
Feat.
K. Patel
04:15
Indy Hematology Review
Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…
Feat.
M. Gertz
13:18
Insights from 2023 IMS Annual Meeting
Highlights and Key Takeaways From the 2023 International Myeloma Soc…
Feat.
A. Jakubowiak
05:56
ASH 2022 Conference Coverage
ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalido…
Feat.
G. Morgan
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
13:36
Vanderbilt University Medical Center (VUMC)
Venous Thromboembolism Prophylaxis in Newly Diagnosed MM
Feat.
M. Baljevic
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
05:22
PrecisCa
Teclistamab in R/R Multiple Myeloma: Results From the MajesTEC-1 Tri…
Feat.
A. Nooka
04:31
ASH 2022 Conference Coverage
ASH 2022 GRIFFIN Trial Final Analysis: D-RVd in Clinically Relevant …
Feat.
A. Chari
52:39
Yale Cancer Center
Myeloma in 2023: So Many Drugs, Yet So Few Cures
Feat.
A. Chari
